UC-MSC Therapy
Stem cells from umbilical cord | Young cell-derived regenerative medicine
이 치료에 대해
UC-MSC therapy uses stem cells harvested from umbilical cord at birth—available only once, making cells particularly young and active. Secretes EGF, FGF, VEGF in high quantities.
Supports cellular proliferation and differentiation, promotes wound healing. Suppresses inflammatory responses, improving inflammation-prone aging skin and restoring texture and firmness. Compensates for age-related decline in stem cell function with youthful cells.
작용 기전
UC-MSC-secreted factors (EGF, FGF, VEGF) act on dermal fibroblasts, promoting proliferation, differentiation, and collagen production. Simultaneously produces anti-inflammatory cytokines (IL-10, TGF-β) while suppressing pro-inflammatory ones (IL-6). Reduces skin inflammation, improves barrier function. Promotes neovascularization, enhancing tissue oxygen supply.
적응증
기대 효과
Post-UC-MSC administration, inflammatory markers (CRP, IL-6) decrease. Skin elasticity and hydration improve, sensitive skin calms. Typically perceive improvement at 3-6 months.
임상 근거
위험 및 부작용
Infection risk during umbilical cord collection (facility-dependent). Cell viability reduction during storage. Post-injection immune response rare but theoretical risk exists due to non-autologous nature.